A citation-based method for searching scientific literature

Aniello Cerrato, Roberta Visconti, Angela Celetti. Mol Cancer 2018
Times Cited: 12







List of co-cited articles
34 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Fusions in solid tumours: diagnostic strategies, targeted therapy, and acquired resistance.
Alison M Schram, Matthew T Chang, Philip Jonsson, Alexander Drilon. Nat Rev Clin Oncol 2017
133
25

The landscape of kinase fusions in cancer.
Nicolas Stransky, Ethan Cerami, Stefanie Schalm, Joseph L Kim, Christoph Lengauer. Nat Commun 2014
514
25

Driver Fusions and Their Implications in the Development and Treatment of Human Cancers.
Qingsong Gao, Wen-Wei Liang, Steven M Foltz, Gnanavel Mutharasu, Reyka G Jayasinghe, Song Cao, Wen-Wei Liao, Sheila M Reynolds, Matthew A Wyczalkowski, Lijun Yao,[...]. Cell Rep 2018
185
25

RET, ROS1 and ALK fusions in lung cancer.
Kengo Takeuchi, Manabu Soda, Yuki Togashi, Ritsuro Suzuki, Seiji Sakata, Satoko Hatano, Reimi Asaka, Wakako Hamanaka, Hironori Ninomiya, Hirofumi Uehara,[...]. Nat Med 2012
851
25

CCDC6 and USP7 expression levels suggest novel treatment options in high-grade urothelial bladder cancer.
Francesco Morra, Francesco Merolla, Daniela Criscuolo, Luigi Insabato, Riccardo Giannella, Gennaro Ilardi, Aniello Cerrato, Roberta Visconti, Stefania Staibano, Angela Celetti. J Exp Clin Cancer Res 2019
18
25

Ccdc6 knock-in mice develop thyroid hyperplasia associated to an enhanced CREB1 activity.
Vincenza Leone, Concetta Langella, Francesco Esposito, Claudio Arra, Giuseppe Palma, Domenica Rea, Orlando Paciello, Francesco Merolla, Davide De Biase, Serenella Papparella,[...]. Oncotarget 2015
19
25

Lorlatinib in non-small-cell lung cancer with ALK or ROS1 rearrangement: an international, multicentre, open-label, single-arm first-in-man phase 1 trial.
Alice T Shaw, Enriqueta Felip, Todd M Bauer, Benjamin Besse, Alejandro Navarro, Sophie Postel-Vinay, Justin F Gainor, Melissa Johnson, Jorg Dietrich, Leonard P James,[...]. Lancet Oncol 2017
316
16

OncoKB: A Precision Oncology Knowledge Base.
Debyani Chakravarty, Jianjiong Gao, Sarah M Phillips, Ritika Kundra, Hongxin Zhang, Jiaojiao Wang, Julia E Rudolph, Rona Yaeger, Tara Soumerai, Moriah H Nissan,[...]. JCO Precis Oncol 2017
720
16

Anchored multiplex PCR for targeted next-generation sequencing.
Zongli Zheng, Matthew Liebers, Boryana Zhelyazkova, Yi Cao, Divya Panditi, Kerry D Lynch, Juxiang Chen, Hayley E Robinson, Hyo Sup Shim, Juliann Chmielecki,[...]. Nat Med 2014
493
16

Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden.
Matthew D Hellmann, Tudor-Eliade Ciuleanu, Adam Pluzanski, Jong Seok Lee, Gregory A Otterson, Clarisse Audigier-Valette, Elisa Minenza, Helena Linardou, Sjaak Burgers, Pamela Salman,[...]. N Engl J Med 2018
16

Validation of a Targeted RNA Sequencing Assay for Kinase Fusion Detection in Solid Tumors.
Julie W Reeser, Dorrelyn Martin, Jharna Miya, Esko A Kautto, Ezra Lyon, Eliot Zhu, Michele R Wing, Amy Smith, Matthew Reeder, Eric Samorodnitsky,[...]. J Mol Diagn 2017
37
16

The landscape and therapeutic relevance of cancer-associated transcript fusions.
K Yoshihara, Q Wang, W Torres-Garcia, S Zheng, R Vegesna, H Kim, R G W Verhaak. Oncogene 2015
272
16

The emerging complexity of gene fusions in cancer.
Fredrik Mertens, Bertil Johansson, Thoas Fioretos, Felix Mitelman. Nat Rev Cancer 2015
332
16

Clinical and Translational Implications of RET Rearrangements in Non-Small Cell Lung Cancer.
Roberto Ferrara, Nathalie Auger, Edouard Auclin, Benjamin Besse. J Thorac Oncol 2018
75
16

The combined effect of USP7 inhibitors and PARP inhibitors in hormone-sensitive and castration-resistant prostate cancer cells.
Francesco Morra, Francesco Merolla, Virginia Napolitano, Gennaro Ilardi, Caterina Miro, Simona Paladino, Stefania Staibano, Aniello Cerrato, Angela Celetti. Oncotarget 2017
41
16

FBXW7 and USP7 regulate CCDC6 turnover during the cell cycle and affect cancer drugs susceptibility in NSCLC.
Francesco Morra, Chiara Luise, Francesco Merolla, Ina Poser, Roberta Visconti, Gennaro Ilardi, Simona Paladino, Hiroyuki Inuzuka, Gianluca Guggino, Roberto Monaco,[...]. Oncotarget 2015
32
16

Involvement of H4(D10S170) protein in ATM-dependent response to DNA damage.
F Merolla, F Pentimalli, R Pacelli, G Vecchio, A Fusco, M Grieco, A Celetti. Oncogene 2007
36
16


H4(D10S170), a gene frequently rearranged with RET in papillary thyroid carcinomas: functional characterization.
Angela Celetti, Aniello Cerrato, Francesco Merolla, Donata Vitagliano, Giancarlo Vecchio, Michele Grieco. Oncogene 2004
51
16

FKBP51 Immunohistochemical Expression: A New Prognostic Biomarker for OSCC?
Daniela Russo, Francesco Merolla, Massimo Mascolo, Gennaro Ilardi, Simona Romano, Silvia Varricchio, Virginia Napolitano, Angela Celetti, Loredana Postiglione, Pier Paolo Di Lorenzo,[...]. Int J Mol Sci 2017
21
16

Loss of CCDC6, the first identified RET partner gene, affects pH2AX S139 levels and accelerates mitotic entry upon DNA damage.
Francesco Merolla, Chiara Luise, Mark T Muller, Roberto Pacelli, Alfredo Fusco, Angela Celetti. PLoS One 2012
25
16

CCDC6: the identity of a protein known to be partner in fusion.
Aniello Cerrato, Francesco Merolla, Francesco Morra, Angela Celetti. Int J Cancer 2018
16
16

USP7 inhibitors, downregulating CCDC6, sensitize lung neuroendocrine cancer cells to PARP-inhibitor drugs.
Umberto Malapelle, Francesco Morra, Gennaro Ilardi, Roberta Visconti, Francesco Merolla, Aniello Cerrato, Virginia Napolitano, Roberto Monaco, Gianluca Guggino, Guglielmo Monaco,[...]. Lung Cancer 2017
39
16

QuPath: Open source software for digital pathology image analysis.
Peter Bankhead, Maurice B Loughrey, José A Fernández, Yvonne Dombrowski, Darragh G McArt, Philip D Dunne, Stephen McQuaid, Ronan T Gray, Liam J Murray, Helen G Coleman,[...]. Sci Rep 2017
16

PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas.
M Grieco, M Santoro, M T Berlingieri, R M Melillo, R Donghi, I Bongarzone, M A Pierotti, G Della Porta, A Fusco, G Vecchio. Cell 1990
809
16


New therapeutic perspectives in CCDC6 deficient lung cancer cells.
Francesco Morra, Chiara Luise, Roberta Visconti, Stefania Staibano, Francesco Merolla, Gennaro Ilardi, Gianluca Guggino, Simona Paladino, Daniela Sarnataro, Renato Franco,[...]. Int J Cancer 2015
37
16

Molecular basis of USP7 inhibition by selective small-molecule inhibitors.
Andrew P Turnbull, Stephanos Ioannidis, Wojciech W Krajewski, Adan Pinto-Fernandez, Claire Heride, Agnes C L Martin, Louise M Tonkin, Elizabeth C Townsend, Shane M Buker, David R Lancia,[...]. Nature 2017
173
16


The between Now and Then of Lung Cancer Chemotherapy and Immunotherapy.
Roberta Visconti, Francesco Morra, Gianluca Guggino, Angela Celetti. Int J Mol Sci 2017
29
16




Analysis of CCDC6 as a novel biomarker for the clinical use of PARP1 inhibitors in malignant pleural mesothelioma.
Francesco Morra, Francesco Merolla, Debora D'Abbiero, Gennaro Ilardi, Severo Campione, Roberto Monaco, Gianluca Guggino, Francesca Ambrosio, Stefania Staibano, Aniello Cerrato,[...]. Lung Cancer 2019
7
28

The oncogenic lung cancer fusion kinase CD74-ROS activates a novel invasiveness pathway through E-Syt1 phosphorylation.
Hyun Jung Jun, Hannah Johnson, Roderick T Bronson, Sebastien de Feraudy, Forest White, Alain Charest. Cancer Res 2012
58
8

Molecular pathways: ROS1 fusion proteins in cancer.
Kurtis D Davies, Robert C Doebele. Clin Cancer Res 2013
198
8

The WNKs: atypical protein kinases with pleiotropic actions.
James A McCormick, David H Ellison. Physiol Rev 2011
167
8

Ceritinib in ALK-rearranged non-small-cell lung cancer.
Alice T Shaw, Dong-Wan Kim, Ranee Mehra, Daniel S W Tan, Enriqueta Felip, Laura Q M Chow, D Ross Camidge, Johan Vansteenkiste, Sunil Sharma, Tommaso De Pas,[...]. N Engl J Med 2014
8

New somatic mutations and WNK1-B4GALNT3 gene fusion in papillary thyroid carcinoma.
Valerio Costa, Roberta Esposito, Carmela Ziviello, Romina Sepe, Larissa Valdemarin Bim, Nunzio Antonio Cacciola, Myriam Decaussin-Petrucci, Pierlorenzo Pallante, Alfredo Fusco, Alfredo Ciccodicola. Oncotarget 2015
36
8

Acquired resistance to crizotinib from a mutation in CD74-ROS1.
Mark M Awad, Jeffrey A Engelman, Alice T Shaw. N Engl J Med 2013
27
8

Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers.
Aaron M Goodman, Shumei Kato, Lyudmila Bazhenova, Sandip P Patel, Garrett M Frampton, Vincent Miller, Philip J Stephens, Gregory A Daniels, Razelle Kurzrock. Mol Cancer Ther 2017
975
8

Durable Response to Afatinib in Lung Adenocarcinoma Harboring NRG1 Gene Fusions.
Nathan D Gay, Ying Wang, Carol Beadling, Andrea Warrick, Tanaya Neff, Christopher L Corless, Khaled Tolba. J Thorac Oncol 2017
39
8

Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapes.
Alexander Drilon, Zishuo I Hu, Gillianne G Y Lai, Daniel S W Tan. Nat Rev Clin Oncol 2018
29
8

Clinical characteristics and outcome of patients with lung cancer harboring BRAF mutations.
Claire Tissot, Sébastien Couraud, Ronan Tanguy, Pierre-Paul Bringuier, Nicolas Girard, Pierre-Jean Souquet. Lung Cancer 2016
77
8

Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children.
Alexander Drilon, Theodore W Laetsch, Shivaani Kummar, Steven G DuBois, Ulrik N Lassen, George D Demetri, Michael Nathenson, Robert C Doebele, Anna F Farago, Alberto S Pappo,[...]. N Engl J Med 2018
8


Identification of KIF5B-RET and GOPC-ROS1 fusions in lung adenocarcinomas through a comprehensive mRNA-based screen for tyrosine kinase fusions.
Yoshiyuki Suehara, Maria Arcila, Lu Wang, Adnan Hasanovic, Daphne Ang, Tatsuo Ito, Yuki Kimura, Alexander Drilon, Udayan Guha, Valerie Rusch,[...]. Clin Cancer Res 2012
130
8

Continuous fluorescence monitoring of rapid cycle DNA amplification.
C T Wittwer, M G Herrmann, A A Moss, R P Rasmussen. Biotechniques 1997
914
8

Targeted next generation sequencing identifies somatic mutations and gene fusions in papillary thyroid carcinoma.
Zheming Lu, Yujie Zhang, Dongdong Feng, Jindong Sheng, Wenjun Yang, Baoguo Liu. Oncotarget 2017
25
8

Oncogene addiction in non-small cell lung cancer: Focus on ROS1 inhibition.
Francesco Facchinetti, Giulio Rossi, Emilio Bria, Jean-Charles Soria, Benjamin Besse, Roberta Minari, Luc Friboulet, Marcello Tiseo. Cancer Treat Rev 2017
43
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.